CN109797189A - A kind of identification of target cell and killing method - Google Patents
A kind of identification of target cell and killing method Download PDFInfo
- Publication number
- CN109797189A CN109797189A CN201910027891.2A CN201910027891A CN109797189A CN 109797189 A CN109797189 A CN 109797189A CN 201910027891 A CN201910027891 A CN 201910027891A CN 109797189 A CN109797189 A CN 109797189A
- Authority
- CN
- China
- Prior art keywords
- cell
- ctl
- sample
- target cell
- nkg2d
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a kind of identifications of target cell and killing method, comprising: cultivates the NK cell with high expression NKg2d;Cultivate the CTL cell with high activity;NK cell with high expression NKg2d and the CTL cell with high activity are injected into abnormal target cell sample, under its microenvironment, the part NKg2d of NK cell secretion is entrenched in CTL cell surface of the same race, restore the identification and killing ability of CTL cell, CTL cell is realized to the target cell identification of the MHC-1 class molecule positive, killing and is removed, the restricted feature of non-MHC-1 for applying NK cell simultaneously, is identified, killed and is removed to the target cell of non-MHC-1 class molecule feminine gender.
Description
Technical field
The present invention relates to cell field more particularly to a kind of identifications of target cell and killing method.
Background technique
There are in the sample of abnormal target cell, the identification receptor NKg2d of CTL cell surface, which is easy to fall off, causes it to exception
The recognition performance of target cell declines, it is difficult to kill the abnormal target cell of low expression MHC-1 class molecule.
Summary of the invention
For overcome the deficiencies in the prior art, the purpose of the present invention is to provide a kind of identifications of target cell and killing side
Method, to identify and kill abnormal target cell.
The purpose of the present invention adopts the following technical scheme that realization:
A kind of identification of target cell and killing method, comprising:
Cultivate the NK cell with high expression NKg2d;
Cultivate the CTL cell with high activity;
NK cell with high expression NKg2d and the CTL cell with high activity are injected into abnormal target cell sample, so that
Part NKg2d is adhered to the CTL cell.
Further, it cultivates before there is the high NK cell for expressing NKg2d further include:
NK cell sample and CTL cell sample are extracted from sample.
Further, after extracting NK cell sample and CTL cell sample in sample further include:
The NK cell sample and the CTL cell sample are separated, cultivated and expanded.
Compared with prior art, the beneficial effects of the present invention are: by the NK cell with high expression NKg2d and have high living
Property CTL cell inject abnormal target cell sample so that part NKg2d is adhered to CTL cell, to make the release of CTL cell
Granzyme, lysosome, perforin, Fas, IFN etc., realize CTL cell to the identification of the target cell of MHC-1 class molecule positive, kill and
It removes, while the restricted feature of non-MHC-1 of application NK cell, the target cell of non-MHC-1 class molecule feminine gender is identified, is killed
Wound and removing.
Detailed description of the invention
Fig. 1 is the identification and killing method of target cell provided in an embodiment of the present invention.
Specific embodiment
In the following, being described further in conjunction with attached drawing and specific embodiment to the present invention, it should be noted that not
Under the premise of conflicting, new implementation can be formed between various embodiments described below or between each technical characteristic in any combination
Example.
As shown in Figure 1, the identification of target cell provided in an embodiment of the present invention and killing method, comprising:
Step S101: the NK cell with high expression NKg2d is cultivated.
Preferably, extracting NK cell sample and CTL cell sample from sample, wherein sample before cultivating NK cell
Same main body is come from target cell, NK cell normal expression NKg2d, the CTL cell surface in sample has NKg2d.Extract NK
After cell sample and CTL cell sample, NK cell sample and the CTL cell sample are separated, cultivated and expanded, is passed through
Existing breeding method cultivates the NK cell of high expression NKg2d.
Step S102: the CTL cell with high activity is cultivated.
Specifically, cultivating the CTL cell of high activity so that CTL cell is effectively combined with NKg2d.
Step S103: the NK cell with high expression NKg2d and the CTL cell with high activity are injected into abnormal target cell
Sample, so that part NKg2d is adhered to the CTL cell.
Specifically, abnormal target cell is easily parasitic or is gathered in solid tissue or organ, the CTL in abnormal target cell sample is thin
The decline of born of the same parents' performance, the NKg2d on surface fall off, and cannot kill mutant.By the NK cell with high expression NKg2d and there is height
Active CTL cell successively injects abnormal target cell sample, in abnormal target cell sample environment, the part of NK cell secretion
NKg2d adaptively carries or is embedded in automatically CTL cell surface of the same race, to improve CTL cell to the identification energy of abnormal target cell
Power, while granzyme is discharged, lysosome, perforin, Fas, IFN etc., using the targeting of CTL cell to MHC-1 class molecule sun
Property target cell identification, killing and remove;The restricted feature of non-MHC-1 for utilizing NK cell simultaneously, to non-MHC-1 class molecule yin
Property target cell identified, killed and removed, to the identification of the target cell of different type and property, killing and remove.
The identification and killing method of target cell provided by the invention by the NK cell with high expression NKg2d and have height
Active CTL cell injects abnormal target cell sample, so that part NKg2d is adhered to CTL cell, restores the identification of CTL cell
With killing ability, to make CTL cell released both particle enzyme, lysosome, perforin, Fas, IFN etc. realize CTL cell to MHC-1
Target cell identification, killing and the removing of the class molecule positive, while the restricted feature of non-MHC-1 of application NK cell, to non-MHC-1
The target cell of class molecule feminine gender is identified, killed and is removed.
The above embodiment is only the preferred embodiment of the present invention, and the scope of protection of the present invention is not limited thereto,
The variation and replacement for any unsubstantiality that those skilled in the art is done on the basis of the present invention belong to institute of the present invention
Claimed range.
Claims (3)
1. a kind of identification of target cell and killing method characterized by comprising
Cultivate the NK cell with high expression NKg2d;
Cultivate the CTL cell with high activity;
NK cell with high expression NKg2d and the CTL cell with high activity are injected into abnormal target cell sample, so that part
NKg2d is adhered to the CTL cell surface.
2. the identification of target cell according to claim 1 and killing method, which is characterized in that cultivating has high expression
Before the NK cell of NKg2d further include:
NK cell sample and CTL cell sample are extracted from sample.
3. the identification of target cell according to claim 2 and killing method, which is characterized in that it is thin to isolate NK from sample
After born of the same parents' sample and CTL cell sample further include:
The NK cell sample and the CTL cell sample are separated, cultivated and expanded.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910027891.2A CN109797189A (en) | 2019-01-11 | 2019-01-11 | A kind of identification of target cell and killing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910027891.2A CN109797189A (en) | 2019-01-11 | 2019-01-11 | A kind of identification of target cell and killing method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109797189A true CN109797189A (en) | 2019-05-24 |
Family
ID=66557074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910027891.2A Pending CN109797189A (en) | 2019-01-11 | 2019-01-11 | A kind of identification of target cell and killing method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109797189A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090068141A1 (en) * | 2006-03-06 | 2009-03-12 | The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services | Autologous natural killer cells and lymphodepleting chemotherapy for the treatment of cancer |
CN101495864A (en) * | 2006-04-12 | 2009-07-29 | 硅生物系统股份公司 | Diagnostic and therapeutic application of CTL and NK functionally selected cells |
CN103800898A (en) * | 2014-03-13 | 2014-05-21 | 蔡颖 | Tumor specific killer cell preparation and preparation method thereof |
US20140377266A1 (en) * | 2011-09-09 | 2014-12-25 | Fred Hutchinson Cancer Research Center | Methods and Compositions Involving NKG2D Inhibitors and Cancer |
CN106011060A (en) * | 2016-06-29 | 2016-10-12 | 北京中台恒基生物技术有限公司 | In-vitro activation and amplification method of NKT-like cells |
CN109071679A (en) * | 2016-02-05 | 2018-12-21 | 华盛顿大学 | The composition and method that cell factor for targeting delivers |
-
2019
- 2019-01-11 CN CN201910027891.2A patent/CN109797189A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090068141A1 (en) * | 2006-03-06 | 2009-03-12 | The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services | Autologous natural killer cells and lymphodepleting chemotherapy for the treatment of cancer |
CN101495864A (en) * | 2006-04-12 | 2009-07-29 | 硅生物系统股份公司 | Diagnostic and therapeutic application of CTL and NK functionally selected cells |
US20140377266A1 (en) * | 2011-09-09 | 2014-12-25 | Fred Hutchinson Cancer Research Center | Methods and Compositions Involving NKG2D Inhibitors and Cancer |
CN103800898A (en) * | 2014-03-13 | 2014-05-21 | 蔡颖 | Tumor specific killer cell preparation and preparation method thereof |
CN109071679A (en) * | 2016-02-05 | 2018-12-21 | 华盛顿大学 | The composition and method that cell factor for targeting delivers |
CN106011060A (en) * | 2016-06-29 | 2016-10-12 | 北京中台恒基生物技术有限公司 | In-vitro activation and amplification method of NKT-like cells |
Non-Patent Citations (4)
Title |
---|
"Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease" * |
MARKIEWICZ MA等: "Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation" * |
周双念: "自体双活化靶向免疫技术系统(NKg2d-CTL)的临床应用研究" * |
曾小辉: "原发性肝癌外周血NK细胞受体NKG2D表达和NK细胞亚群分布的变化及意义" * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110037979B (en) | Sheep mesenchymal stem cell-containing exosome freeze-dried powder and preparation method thereof | |
CN101608174A (en) | A kind of construction process of human umbilical cord mesenchyma stem cell | |
CN105238736B (en) | A kind of cultural method of dendrobium candidum stem cell and its application | |
WO2006052925A3 (en) | Cardiac stem cells | |
IL160090A0 (en) | Device for and method of controlled enzymatic removal and retrieval of tissue | |
NZ593364A (en) | Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture | |
WO2012170340A3 (en) | Insertable neural probe with flexible structure | |
CN103393585B (en) | Fibroblast liquid for beauty treatment and preparation method thereof | |
US10368980B2 (en) | Middle ear mucosa-like cell sheet, process of producing the same and method of using the same | |
CN104814980A (en) | Production method and applications of human embryo fibroblasts | |
JP2008526318A5 (en) | ||
CN102965338A (en) | Extraction and culture method of human umbilical cord mesenchymal stem cells | |
CN104450606B (en) | Sweat gland cells inducing culture and its application | |
AU2015274627A1 (en) | Inhibiting or reducing fungal infections | |
CN109797189A (en) | A kind of identification of target cell and killing method | |
Kishta et al. | Mesenchymal stem cells seeded onto nanofiber scaffold for myocardial regeneration | |
WO2004011631A3 (en) | Methods and compositions for treating tissue defects using pulsed electromagnetic field stimulus | |
CN109320591A (en) | A kind of polypeptide OA-GL12 and its application | |
CN104399122A (en) | Acellular matrix and preparation method thereof | |
WO2020143043A1 (en) | Method for identifying and killing target cell | |
CN102747137B (en) | Identifying method for sunflower phoma black stem bacteria | |
CN104911142B (en) | A kind of in vitro separation and culture method and application of deer corium hair papilla cell | |
CN113332313A (en) | Stem cell preparation for treating seborrheic alopecia | |
CN107661569A (en) | One kind is used for the oxidation resistant stem cell processed material micropin of skin | |
CN109097321A (en) | A kind of primary separation method of hair follicle stem cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |